| [1] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
|
| [2] |
Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries[J]. Lancet Glob Health, 2018, 6(5):e555-567.
|
| [3] |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1):7-30.
|
| [4] |
Kamisawa T, Wood LD, Itoi T, et al. Pancreatic cancer[J]. Lancet, 2016, 388(10039):73-85.
|
| [5] |
Japan Pancreas Society. Classification of pancreatic carcinoma[M]. 4th English. Tokyo: Kanehara & Co. Ltd, 2017.
|
| [6] |
Burke EE, Marmor S, Virnig BA, et al. Lymph node evaluation for pancreatic adenocarcinoma and its value as a quality metric[J].J Gastrointest Surg, 2015, 19(12):2162-2170.
|
| [7] |
Egawa S, Takeda K, Fukuyama S, et al. Clinicopathological aspects of small pancreatic cancer[J]. Pancreas, 2004, 28(3):235-240.
|
| [8] |
Zhan HX, Xu JW, Wang L, et al. Lymph node ratio is an independent prognostic factor for patients after resection of pancreatic cancer[J]. World J Surg Oncol, 2015, 13:105.
|
| [9] |
Ashfaq A, Pockaj BA, Gray RJ, et al. Nodal counts and lymph node ratio impact survival after distal pancreatectomy for pancreatic adenocarcinoma[J]. J Gastrointest Surg, 2014, 18(11):1929-1935.
|
| [10] |
Murakami Y, Uemura K, Sudo T, et al. Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma[J]. J Am Coll Surg, 2010, 211(2):196-204.
|
| [11] |
Opfermann KJ, Wahlquist AE, Garrett-Mayer E, et al. Adjuvant radiotherapy and lymph node status for pancreatic cancer: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data[J]. Am J Clin Oncol, 2014, 37(2):112-116.
|
| [12] |
Tol JA, Gouma DJ, Bassi C, et al. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)[J]. Surgery, 2014, 156(3):591-600.
|
| [13] |
Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2017, 15(8):1028-1061.
|
| [14] |
Ishikawa O, Ohhigashi H, Sasaki Y, et al. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head[J]. Ann Surg, 1988, 208(2):215-220.
|
| [15] |
Manabe T, Ohshio G, Baba N, et al. Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas[J]. Cancer, 1989, 64(5):1132-1137.
|
| [16] |
Orci LA, Meyer J, Combescure C, et al. A meta-analysis of extended versus standard lymphadenectomy in patients undergoing pancreatoduodenectomy for pancreatic adenocarcinoma[J]. HPB, 2015, 17(7):565-572.
|
| [17] |
Dasari BV, Pasquali S, Vohra RS, et al. Extended versus standard lymphadenectomy for pancreatic head cancer: meta-analysis of randomized controlled trials[J]. J Gastrointest Surg, 2015, 19(9):1725-1732.
|
| [18] |
Peparini N, Chirletti P. Extended lymphadenectomy does not improve prognosis in pancreatic carcinoma: is that really so?[J]. J Hepatobiliary Pancreat Sci, 2012, 19(3):297-298.
|
| [19] |
陈汝福，周泉波．胰腺癌淋巴结扩大清扫的价值[J]．中国普外基础与临床杂志，2018, 25(6):653-656.
|
| [20] |
Agalianos C, Gouvas N, Papaparaskeva K, et al. Positive para-aortic lymph nodes following pancreatectomy for pancreatic cancer. systematic review and meta-analysis of impact on short term survival and association with clinicopathologic features[J]. HPB, 2016, 18(8):633-641.
|
| [21] |
Schwarz L, Lupinacci RM, Svrcek M, et al. Para-aortic lymph node sampling in pancreatic head adenocarcinoma[J]. Br J Surg, 2014, 101(5):530-538.
|
| [22] |
van Rijssen LB, Narwade P, van Huijgevoort NC, et al. Prognostic value of lymph node metastases detected during surgical exploration for pancreatic or periampullary cancer: a systematic review and meta-analysis[J]. HPB, 2016, 18(7):559-566.
|
| [23] |
Sho M, Murakami Y, Motoi F, et al. Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis:a multicenter study on 822 patients[J]. J Gastroenterol, 2015, 50(6): 694-702.
|
| [24] |
Sperti C, Gruppo M, Blandamura S, et al. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer[J]. World J Gastroenterol, 2017, 23(24):4399-4406.
|
| [25] |
Hempel S, Plodeck V, Mierke F, et al. Para-aortic lymph node metastases in pancreatic cancer should not be considered a watershed for curative resection[J]. Sci Rep, 2017, 7(1):7688.
|
| [26] |
Liu C, Chen R, Chen Y, et al. Should a standard lymphadenectomy during pancreatoduodenectomy exclude para-aortic lymph nodes for all cases of resectable pancreatic head cancer? a consensus statement by the Chinese Study Group for Pancreatic Cancer (CSPAC)[J]. Int J Oncol, 2015, 47(4):1512-1516.
|
| [27] |
勾善淼，吴河水．胰腺癌根治术淋巴结清扫范围的发展历程[J]．临床肝胆病杂志，2017, 33(1): 57-60.
|
| [28] |
Kang Y, Pantel K. Tumor cell dissemination: emerging biological insights from animal models and cancer patients[J]. Cancer Cell, 2013, 23(5):573-581.
|
| [29] |
Pommier A, Anaparthy N, Memos N, et al. Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases[J]. Science, 2018, 360(6394):eaao4908.
|